1Gavriel Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol, 1992,119: 498-501.
2Wijsman JH, Joaker RR, Keijzer R, et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem, 1993,41:7-12.
3Higaki K, Yano H, Kojiro M, Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues, Am J Pathol, 1996,149:429-437.
4Hino K, Higashi T, Nouso K, et al. Apoptosis and proliferation of human hepatocellular carcinoma. Liver, 1996,16:123-129.
5Venugopal P, Gezer S, Hines C, et al. In situ double-labeling with two enzymatic reactions to distinguish specilis DNA fragmentation patterns in apoptosis cell death, Pro Am Assoc Cancer Res, 1996,37:184.
6Stahelin BJ, Marti U, Solioz M, et al. False positive staining in TUNEL assay is due to release of endogenous Dnase and inhibited by diethyl-pyrocarhonate (DEPC) in liver tissue. Hepatology, 1996,4:268.
7Shi SR, Cote RJ, Young LL, et al. Antigen retrieval immunohistochemistry:praetice and development, J Histotechnol,1997,20:145-150.
8Patel T, Arora A, Gores GJ. A fluorometric assay for quantitating DNA strand breaks during apoptosis.Anal Biochem,1995,229:229-235.
